Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theranostics

Showing results (1171-1180 of 5,510) with videos related to

Pageof 551
Sort By:
Theranostics|June 10, 2024
Distinctive tumorigenic significance and innovative oncology targets of SUMOylationHeng Zhou, Na Deng, Yanshu Li, et al.
Theranostics|June 10, 2024
Combined activation of artificial and natural ion channels for disrupting mitochondrial ion homeostasis towards effective postoperative tumor recurrence and metastasis suppressionPanqin Ma, Zheng Luo, Qi Wang, et al.
Theranostics|June 10, 2024
Erratum: Exosomal miR-125b-5p deriving from mesenchymal stem cells promotes tubular repair by suppression of p53 in ischemic acute kidney injury: ErratumJing-Yuan Cao, Bin Wang, Tao-Tao Tang, et al.
Theranostics|June 10, 2024
Stem cell-derived extracellular vesicles in the therapeutic intervention of Alzheimer's Disease, Parkinson's Disease, and strokeWantong Zhou, Xudong Wang, Yumeng Dong, et al.
Theranostics|November 1, 2023
Stimuli-activatable nanomedicine meets cancer theranosticsHaonan Li, Yue Feng, Qiang Luo, et al.
Theranostics|November 1, 2023
1α,25(OH)<sub>2</sub>D<sub>3</sub> ameliorates insulin resistance by alleviating γδ T cell inflammation via enhancing fructose-1,6-bisphosphatase 1 expressionPeng Li, Ke Li, Wenhui Yuan, et al.
Theranostics|November 1, 2023
Fe(III)-Shikonin supramolecular nanomedicines as immunogenic cell death stimulants and multifunctional immunoadjuvants for tumor vaccinationWenjie Feng, Wanrui Shi, Yanqi Cui, et al.
Theranostics|November 1, 2023
Aptamer-engineered (nano)materials for theranostic applicationsNavid Rabiee, Suxiang Chen, Sepideh Ahmadi, et al.
Theranostics|November 1, 2023
<i>In vivo</i> nanoparticle-based T cell imaging can predict therapy response towards adoptive T cell therapy in experimental gliomaJessica Hunger, Katharina Schregel, Berin Boztepe, et al.
Theranostics|March 20, 2024
An advanced comprehensive muti-cell-type-specific model for predicting anti-PD-1 therapeutic effect in melanomaWei Sun, Yu Zhu, Zijian Zou, et al.
Pageof 551

Showing results (1171-1180 of 5,510) with videos related to

Sort By:
Pageof 551
Theranostics|June 10, 2024
Distinctive tumorigenic significance and innovative oncology targets of SUMOylationHeng Zhou, Na Deng, Yanshu Li, et al.
Theranostics|June 10, 2024
Combined activation of artificial and natural ion channels for disrupting mitochondrial ion homeostasis towards effective postoperative tumor recurrence and metastasis suppressionPanqin Ma, Zheng Luo, Qi Wang, et al.
Theranostics|June 10, 2024
Erratum: Exosomal miR-125b-5p deriving from mesenchymal stem cells promotes tubular repair by suppression of p53 in ischemic acute kidney injury: ErratumJing-Yuan Cao, Bin Wang, Tao-Tao Tang, et al.
Theranostics|June 10, 2024
Stem cell-derived extracellular vesicles in the therapeutic intervention of Alzheimer's Disease, Parkinson's Disease, and strokeWantong Zhou, Xudong Wang, Yumeng Dong, et al.
Theranostics|November 1, 2023
Stimuli-activatable nanomedicine meets cancer theranosticsHaonan Li, Yue Feng, Qiang Luo, et al.
Theranostics|November 1, 2023
1α,25(OH)<sub>2</sub>D<sub>3</sub> ameliorates insulin resistance by alleviating γδ T cell inflammation via enhancing fructose-1,6-bisphosphatase 1 expressionPeng Li, Ke Li, Wenhui Yuan, et al.
Theranostics|November 1, 2023
Fe(III)-Shikonin supramolecular nanomedicines as immunogenic cell death stimulants and multifunctional immunoadjuvants for tumor vaccinationWenjie Feng, Wanrui Shi, Yanqi Cui, et al.
Theranostics|November 1, 2023
Aptamer-engineered (nano)materials for theranostic applicationsNavid Rabiee, Suxiang Chen, Sepideh Ahmadi, et al.
Theranostics|November 1, 2023
<i>In vivo</i> nanoparticle-based T cell imaging can predict therapy response towards adoptive T cell therapy in experimental gliomaJessica Hunger, Katharina Schregel, Berin Boztepe, et al.
Theranostics|March 20, 2024
An advanced comprehensive muti-cell-type-specific model for predicting anti-PD-1 therapeutic effect in melanomaWei Sun, Yu Zhu, Zijian Zou, et al.
Pageof 551